| 2024-10-14 | Class updated from VUS4 to non disease-causing |
| 2024-12-09 | Variant classified as non-disease-causing on the basis of epidemiological data (in particular high frequency in the general population), the number and type of diagnosis for patients reported in CFTR-France and functional data |
Variant NM_000492.4:c.2506G>T
| Name | NM_000492.4:c.2506G>T |
| Protein name | NP_000483.3:p.(Asp836Tyr) |
| Genomic name (hg19) | chr7:g.117234999G>T UCSC |
| Genomic name (hg38) | chr7:g.117594945G>T UCSC |
| #Exon/intron | exon 15 |
| Legacy Name | D836Y |
| Class | non disease-causing |
| WT sequence | TTTTATTCAGGAGTGCTTTTTTGAT G ATATGGAGAGCATACCAGCAGTGAC |
| Mutant sequence | TTTTATTCAGGAGTGCTTTTTTGAT T ATATGGAGAGCATACCAGCAGTGAC |
![]() |
![]() | dbSNP rs201386642 |
![]() | ![]() |
| Modulator | FDA approval | EMA approval | in vitro / ex vivo data | clinical data |
| IVA | no | no | no | no |
| TEZ-IVA | yes | no | yes | no |
| ELX-TEZ-IVA | yes | no | yes | no |
| VNZ-TEZ-DIVA | yes | no | yes | no |
clinical and functional data presented above are provided by Vertex
No patient found in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 4 |
|---|---|
| Asymptomatic compound heterozygote | 2 |
| CFTR-RD | 2
|
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| CRS-NP | 3098 | heterozygote | |
| Pancreatitis | 5329 | heterozygote | varying clinical consequence- Undef |
| Asymptomatic compound heterozygote | 5308 | heterozygote | |
| Asymptomatic compound heterozygote | 5309 | heterozygote | CF-causing - Trans |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|